vs

Side-by-side financial comparison of HeartCore Enterprises, Inc. (HTCR) and Roivant Sciences Ltd. (ROIV). Click either name above to swap in a different company.

HeartCore Enterprises, Inc. is the larger business by last-quarter revenue ($3.0M vs $2.0M, roughly 1.5× Roivant Sciences Ltd.). HeartCore Enterprises, Inc. runs the higher net margin — 14.5% vs -13301.2%, a 13315.7% gap on every dollar of revenue. On growth, Roivant Sciences Ltd. posted the faster year-over-year revenue change (-77.8% vs -81.6%). Over the past eight quarters, HeartCore Enterprises, Inc.'s revenue compounded faster (-5.2% CAGR vs -73.7%).

HeartCore Enterprises, Inc. is a global SaaS provider specializing in customer experience management, digital transformation solutions, and marketing technology tools. It operates mainly in Japan, Asia-Pacific, and North America, serving small-to-medium businesses and large enterprises with content management systems, marketing automation platforms, and CRM solutions.

Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies. It was founded in 2014 by Vivek Ramaswamy and is currently headed by CEO Matt Gline. Roivant maintains its headquarters in New York City as well as major offices in the biotech hubs of Boston and Basel.

HTCR vs ROIV — Head-to-Head

Bigger by revenue
HTCR
HTCR
1.5× larger
HTCR
$3.0M
$2.0M
ROIV
Growing faster (revenue YoY)
ROIV
ROIV
+3.8% gap
ROIV
-77.8%
-81.6%
HTCR
Higher net margin
HTCR
HTCR
13315.7% more per $
HTCR
14.5%
-13301.2%
ROIV
Faster 2-yr revenue CAGR
HTCR
HTCR
Annualised
HTCR
-5.2%
-73.7%
ROIV

Income Statement — Q3 FY2025 vs Q3 FY2026

Metric
HTCR
HTCR
ROIV
ROIV
Revenue
$3.0M
$2.0M
Net Profit
$434.1K
$-265.9M
Gross Margin
49.1%
Operating Margin
-0.4%
-16966.1%
Net Margin
14.5%
-13301.2%
Revenue YoY
-81.6%
-77.8%
Net Profit YoY
-96.1%
-257.0%
EPS (diluted)
$0.02
$-0.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HTCR
HTCR
ROIV
ROIV
Q4 25
$2.0M
Q3 25
$3.0M
$1.6M
Q2 25
$4.7M
$2.2M
Q1 25
$3.6M
$-39.6M
Q4 24
$-2.7M
$9.0M
Q3 24
$16.2M
$4.5M
Q2 24
$4.1M
$8.0M
Q1 24
$5.0M
$28.9M
Net Profit
HTCR
HTCR
ROIV
ROIV
Q4 25
$-265.9M
Q3 25
$434.1K
$-113.5M
Q2 25
$1.1M
$-223.4M
Q1 25
$-3.1M
$-206.5M
Q4 24
$-9.3M
$169.4M
Q3 24
$11.1M
$-230.2M
Q2 24
$-2.0M
$95.3M
Q1 24
$-1.3M
$-151.1M
Gross Margin
HTCR
HTCR
ROIV
ROIV
Q4 25
Q3 25
49.1%
Q2 25
46.7%
Q1 25
30.7%
Q4 24
Q3 24
86.3%
Q2 24
19.8%
Q1 24
40.3%
Operating Margin
HTCR
HTCR
ROIV
ROIV
Q4 25
-16966.1%
Q3 25
-0.4%
-19492.9%
Q2 25
2.3%
-13130.0%
Q1 25
-34.7%
674.8%
Q4 24
386.5%
-3042.6%
Q3 24
76.0%
-7636.0%
Q2 24
-37.1%
-1279.5%
Q1 24
-13.5%
-919.5%
Net Margin
HTCR
HTCR
ROIV
ROIV
Q4 25
-13301.2%
Q3 25
14.5%
-7225.9%
Q2 25
23.2%
-10292.9%
Q1 25
-86.1%
521.8%
Q4 24
346.8%
1878.3%
Q3 24
68.1%
-5143.8%
Q2 24
-48.0%
1192.7%
Q1 24
-26.4%
-522.3%
EPS (diluted)
HTCR
HTCR
ROIV
ROIV
Q4 25
$-0.38
Q3 25
$0.02
$-0.17
Q2 25
$0.04
$-0.33
Q1 25
$-0.14
$-0.28
Q4 24
$-0.45
$0.23
Q3 24
$0.53
$-0.31
Q2 24
$-0.09
$0.12
Q1 24
$-0.06
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HTCR
HTCR
ROIV
ROIV
Cash + ST InvestmentsLiquidity on hand
$4.4M
$4.5B
Total DebtLower is stronger
$510.9K
Stockholders' EquityBook value
$5.2M
$4.3B
Total Assets
$13.3M
$5.2B
Debt / EquityLower = less leverage
0.10×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HTCR
HTCR
ROIV
ROIV
Q4 25
$4.5B
Q3 25
$4.4M
$4.4B
Q2 25
$2.5M
$4.5B
Q1 25
$2.3M
$4.9B
Q4 24
$6.5M
$5.1B
Q3 24
$8.6M
$5.4B
Q2 24
$4.2M
$5.7B
Q1 24
$1.6M
$6.5B
Total Debt
HTCR
HTCR
ROIV
ROIV
Q4 25
Q3 25
$510.9K
Q2 25
$1.5M
Q1 25
$1.5M
Q4 24
$545.1K
Q3 24
$1.9M
Q2 24
$1.9M
$311.7M
Q1 24
$2.0M
$430.6M
Stockholders' Equity
HTCR
HTCR
ROIV
ROIV
Q4 25
$4.3B
Q3 25
$5.2M
$4.4B
Q2 25
$4.8M
$4.3B
Q1 25
$1.8M
$4.7B
Q4 24
$4.7M
$5.2B
Q3 24
$12.4M
$5.2B
Q2 24
$1.6M
$5.4B
Q1 24
$3.9M
$6.0B
Total Assets
HTCR
HTCR
ROIV
ROIV
Q4 25
$5.2B
Q3 25
$13.3M
$5.1B
Q2 25
$13.5M
$5.0B
Q1 25
$10.2M
$5.4B
Q4 24
$14.0M
$5.8B
Q3 24
$25.5M
$6.2B
Q2 24
$24.1M
$6.5B
Q1 24
$22.3M
$7.2B
Debt / Equity
HTCR
HTCR
ROIV
ROIV
Q4 25
Q3 25
0.10×
Q2 25
0.31×
Q1 25
0.84×
Q4 24
0.12×
Q3 24
0.15×
Q2 24
1.20×
0.06×
Q1 24
0.50×
0.07×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HTCR
HTCR
ROIV
ROIV
Operating Cash FlowLast quarter
$-196.5M
Free Cash FlowOCF − Capex
$-201.4M
FCF MarginFCF / Revenue
-10076.0%
Capex IntensityCapex / Revenue
246.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-776.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HTCR
HTCR
ROIV
ROIV
Q4 25
$-196.5M
Q3 25
$-185.7M
Q2 25
$-674.1K
$-204.4M
Q1 25
$-2.0M
$-172.6M
Q4 24
$-1.3M
$-207.3M
Q3 24
$-1.8M
$-266.8M
Q2 24
$-837.1K
$-192.8M
Q1 24
$-898.6K
$-108.5M
Free Cash Flow
HTCR
HTCR
ROIV
ROIV
Q4 25
$-201.4M
Q3 25
$-193.5M
Q2 25
$-208.4M
Q1 25
$-173.4M
Q4 24
$-209.1M
Q3 24
$-267.8M
Q2 24
$-193.8M
Q1 24
$-108.8M
FCF Margin
HTCR
HTCR
ROIV
ROIV
Q4 25
-10076.0%
Q3 25
-12317.8%
Q2 25
-9604.5%
Q1 25
438.1%
Q4 24
-2318.5%
Q3 24
-5984.4%
Q2 24
-2425.5%
Q1 24
-376.1%
Capex Intensity
HTCR
HTCR
ROIV
ROIV
Q4 25
246.9%
Q3 25
499.6%
Q2 25
185.9%
Q1 25
-2.0%
Q4 24
20.3%
Q3 24
0.0%
22.3%
Q2 24
12.1%
Q1 24
1.2%
Cash Conversion
HTCR
HTCR
ROIV
ROIV
Q4 25
Q3 25
Q2 25
-0.61×
Q1 25
Q4 24
-1.22×
Q3 24
-0.16×
Q2 24
-2.02×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HTCR
HTCR

Customised Software Development And Services$1.7M58%
Software Related Cost Of Revenues$1.4M46%

ROIV
ROIV

Segment breakdown not available.

Related Comparisons